Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis

Thrombosis and Haemostasis

Volumn 101, Issue 3, 2009, Pages 541-546

  Kountourakis, Panteleimon ^a   Psyrri, Amanda ^a,d   Scorilas, Andreas ^b   Markakis, Sonia ^b   Kowaiski, Diane ^a   Camp, Robert L ^a   Diamandis, Eleftherios P ^c   Dimopoulos, Meletios A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c MOUNT SINAI HOSPITAL   (Canada)

^d YALE CANCER CENTER   (United States)

Author keywords

Advanced ovarian cancer; AQUA; Kallikrein related peptidase 8; Prognosis

Indexed keywords

NEUROPSIN;

ADULT; ARTICLE; AUTOMATION; CANCER SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TISSUE MICROARRAY;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; OVARIAN NEOPLASMS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 62549103358     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-01-0052     Document Type: Article

References (32)

1. Jemal A, Tiwari RC, Murray T, et al. American Cancer Society. Cancer statistics 2004. CA Cancer J Clin 2004; 54: 8-29.
2. Meyer T. Rustin GJ. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer 2000; 82: 1535-1538.
3. Paliouras M, Diamandis EP. The kallikrein world: an update on the human tissue kallikreins. Biol Chem 2006; 387: 643-652.
4. Yousef GM. Chang A, Scorilas A, et al. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem Biophys Res Commun 2000; 276: 125-133.
5. Paliouras M, Diamandis EE Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res Treat 2007; 102: 7-18.
6. Shaw JL, Diamandis HP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007; 53: 1423-1432.
7. Talieri M, Diamandis EP, Gourgiotis D, et al. Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb Haemost 2004; 91: 180-186.
8. Shan SJ, Scorilas A, Katsaros D, et al. Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols. Clin Chem 2006; 52: 1879-1886.
9. Diamandis EP. Scorilas A, Fracchioli S, et al. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J Clin Oncol 2003; 21: 1035-1043.
10. Psyrri A, Kountourakis P, Scorilas A, et. al. Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression .Ann Oncol 2008; 19: 1271-1277.
11. Yousef GM, Diamandis EP.Tissue kallikreins: new players in normal and abnormal cell growth? Thromb Haemost 2003: 90: 7-16.
12. Yousef GM, Polymeris ME, Yacoub GM et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res 2003; 63: 2223-2227.
13. Woodhouse EC, Chuaqui RE Liotta LA. General mechanisms of metastasis. Cancer 1997; 80: 1529-1537.
14. Diamandis EP, Yousef GM. Human tissue kallikreins: A family of new cancer biomarkers, Clin Chem 2002; 48: 1198-1205.
15. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays.Nat Med 2002; 8: 1323-1327.
16. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment 16-21 GW: WHO Handbook for Reporting Results of Cancer Treatment. Geneva 1979; 16-21.
17. Rimm DL, Camp RL, Charette LA, et al. Tissue microarray: a new technology for amplification of tissue resources. Cancer J 2001; 7: 24-31.
18. Psyrri A, Kountourakis P, Yu Z, et al. Analysis of p53 Protein Expression Levels on Ovarian Cancer Tissue Microarray using Automated Quantitative Analysis (AQUA) elucidates Prognostic Patient Subsets . Ann Oncol 2007; 18: 709-715.
19. Komatsu N, Saijoh K, Toyama T, et. al. Multiple tissue kallikrein rnRNA and protein expression in normal skin and skin diseases Br J Dermatol 2005; 153: 274-281.
20. Dorn J, Sehmitl M, Kates R, et al. Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients . Clin Cancer Res 2007; 13: 1742-1748.
21. Borgoño CA, Kishi T, Scorilas A, et al. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin Cancer Res 2006; 12: 1487-1493.
22. Psyrri A, Kassar M, Yu Z, et al. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin Cancer Res 2005; 11: 8637-8643.
23. Suzuki J, Yoshida S, Chen Z, et al. Ontogeny of neuropsin in m RNA expression in the mouse brain Neurosci Res 1995; 23: 345-351.
24. Yoshida S, Shiosaka S. Plasticity-related serine proteases in the brain. Int J Mol Med 1999; 3: 405-409.
25. Borgoño CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004; 2: 257-280.
26. Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res 2003; 63: 2771-2774.
27. Yousef GM, Kishi T, Diamandis EP Role of kallikrein enzymes in the central nervous system. Clin Chim Acta 2003; 329: 1-8.
28. Prezas P, Scorilas A, Yfanti C, et al. The role of human tissue kallikreins 7 and 8 in intracranial malignancies. Biol Chem 2006: 387: 1607-1612.
29. Shigemasa K, Tian X, Gu L, et al. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Oncol Rep 2004; 11: 1153-1159.
30. Magklara A, Scorilas A, Katsaros D, et al. The human KI.K8 (neuropsinovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res 2001; 7: 806-811
31. Sher YE Chou CC, Chou RH, et al. Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res 2006; 66: 11763 -11770.
32. Rajapakse S, Ogiwara K, Takano N, et al. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett 2005; 579: 6879-6884.